Summary:
The purpose of the study is to determine the safety and effectiveness of an investigational drug in treating asthma. The investigational drug is a combination of two FDA-approved drugs for the treatment of asthma.
Qualified Participants Must:
• Be at least 18 years old
•
Have experienced stable mild-to-moderate asthma for over 6 months
•
Required asthma medication during prior 4 weeks.
Qualified Participants May Receive:
Compensation for time and travel.